Therapeutic effect of magnesium isoglycyrrhizinate in rats on lung injury induced by Paraquat poisoning

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 3, 2014, Pages 311-320

  Xiao, Z W ^a   Zhang, W ^a   Ma, L ^b   Qiu, Z W ^c  

^a FUZHOU GENERAL HOSPITAL   (China)

^b Emergency Department of Fuzhou General Hospital Nanjing Military Area Command of PLA ^*  (China)

^c Beijing 307 Hospital   (China)

Author keywords

ICAM 1; MGIG; MMP 9; Paraquat

Indexed keywords

GELATINASE B; HYDROXYPROLINE; INTERCELLULAR ADHESION MOLECULE 1; MAGNESIUM DERIVATIVE; MAGNESIUM ISOGLYCYRRHIZINATE; PARAQUAT; SODIUM CHLORIDE; UNCLASSIFIED DRUG; 18ALPHA,20BETA-HYDROXY-11-OXO-NOROLEAN-12-EN-3BETA-YL-2-O-BETA-D-GLUCOPYRANUROSYL-ALPHA-D-GLUCOPYRANOSIDURONATE MAGNESIUM TETRAHYDRATE; SAPONIN; TRITERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG MEGADOSE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; LUNG ALVEOLUS; LUNG FIBROSIS; LUNG INJURY; LUNG PARENCHYMA; MALE; NONHUMAN; PARAQUAT POISONING; PROTEIN EXPRESSION; RAT; THERAPY EFFECT; ANIMAL; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; GENETICS; LUNG; METABOLISM; PATHOLOGY; PULMONARY FIBROSIS; SPRAGUE DAWLEY RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LUNG; LUNG INJURY; MALE; MATRIX METALLOPROTEINASE 9; PARAQUAT; PULMONARY FIBROSIS; RATS, SPRAGUE-DAWLEY; SAPONINS; TRITERPENES;

EID: 84896936352     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. BERRY DJ, GROVE J. The determination of paraquat (I, I'-dimethyl-4, 4'-bipyridylium cation) in urine. Clin Chim Acta 1971; 34: 5-11.
2. BULLIVANT CM. Accidental poisoning by paraquat: Report of two cases in man. Br Med J 1966; 5498: 1272-1273.
3. SMITH LL, LEWIS CP, WYATT I, COHEN GM. The importance of epithelial uptake systems in lung toxicity. Environ Health Perspect 1990; 85: 25-30.
4. VAN DER WAL NA, VAN OIRSCHOT JF, VAN DIJK A, VERHOEF J, VAN ASBECK BS. Mechanism of protection of alveolar type II cells against paraquat-induced cytotoxicity by deferoxamine. Biochem Pharmacol 1990; 39: 1665-1671.
5. YAMASHITA M, YAMASHITA M, ANDO Y. A long-term follow up of lung function in survivors of paraquat poisoning. Hum Exp Toxicol 2000; 19: 99-103.
6. ROSE MS, SMITH LL, WYATT I. Evidence for energydependent accumulation of paraquat into rat lung. Nature 1974; 252: 314-315.
7. VIJEYARATNAM GS, CORRIN B. Experimental paraquat poisoning: a histological and electronoptical study of the changes in the lung. J Pathol 1971; 103: 123-129.
8. DU XD, ZHOU YW, HE B, ZHANG S. Study on the expression of matrix metalloproteinase-9 in lung fibroblasts of rat with acute paraquat poisoning. Sichuan Da Xue Xue Bao Yi Xue Ban 2008; 39: 250-252.
9. ABE K, IKEDA T, WAKE K, SATO T, INOUE H. Glycyrrhizin prevents of lipopolysaccharide/D-galactosamine-induced liver injury through down-regulation of matrix metalloproteinase-9 in mice. J Pharm Pharmacol 2008; 60: 91-97.
10. MENEGAZZI M, DI PAOLA R, MAZZON E, GENOVESE T, CRISAFULLI C, DAL BOSCO M, ZOU Z, SUZUKI H, CUZZOCREA S. Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice. Pharmacol Res 2008; 58: 22-31.
11. SZAPIEL SV, ELSON NA, FULMER JD, HUNNINGHAKE GW, CRYSTAL RG. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis 1979; 120: 893-899.
12. LICKER M, SCHWEIZER A, HOHN L, MOREL DR, SPILIOPOULOS A. Single lung transplantation for adult respiratory distress syndrome after paraquat poisoning. Thorax 1998; 53: 620-621.
13. LIN JL, LIN-TAN DT, CHEN KH, HUANG WH. Repeated pulse of methylprednisolone and cyclophosphamide with continuous dexamethasone therapy for patients with severe paraquat poisoning. Crit Care Med 2006; 34: 368-373.
14. SUNTERS ZE. Role of antiosidants in paraquat toxicity. Toxicology 2002; 180: 65-77.
15. YEH ST, GUO HR, SU YS, LIN HJ, HOU CC, CHEN HM, CHANG MC, WANG YJ. Protective effects of Nacetylcysteine treatment post-acute paraquat intoxication in rats and in human lung epithelial cells. Toxicology 2006; 223: 181-190.
16. MELCHIORRI D, REITER RJ, ATTIA AM, HARA M, BURGOS A, NISTICO G. Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci 1995; 56: 83-89.
17. MELCHIORRI D, REITER RJ, SEWERYNEK E, HARA M, CHEN I, NISTICO G. Paraquat toxicity and oxidative damage reduction by melatonin. Biochem Biochem Pharmacol 1996; 51: 1095-1099.
18. HOET PH, LEWIS CP, DEMEDTS M, NEMERY B. Putrescine and paraquat uptake in human lung slices and isolated type II pneumocytes. Biochem Pharmacol 1994; 48: 517-524.
19. MOHAMMADI-KARAKANI A, GHAZI-KHANSARI M, SOTOUDEH M. Lisinopril ameliorates paraquat-induced lung fibrosis. Clin Chim Acta 2006; 367: 170-174.
20. SITTIPUNT C. Paraquat poisoning. Respir Care 2005; 50: 383-385.
21. BARQUÍN N, CHOU P, RAMOS C, MONTAÑO M, PARDO A, SELMAN M. Increased expression of intercellular adhesion molecule 1, CD11/CD18 cell surface adhesion glycoproteins and 4 1 integrin in a rat model of chronic interstitial lung fibrosis. Pathobiology 1996; 64: 187-192.
22. CORBEL M, THERET N, CAULET-MAUGENDRE S, GERMAIN N, LAGENTE V, CLEMENT B, BOICHOT E. Repeated endotoxin exposure induces interstitial fibrosis associated with enhanced gelatinase (MMP-2 and-MMP-9) activity. Inflamm Res 2001; 50: 129-135.
23. CHEN CM, CHOU HC, HSU HH, WANG LF. Trasforming growth factor-1 upregulation is independent of angiotenain in paraquat-induced lung fibrosis. Toxicology 2005; 216: 181-187.
24. SAENGHIRUNVATTANA S, SERMSWAN A, PIRATCHVEJ V, ROCHANAWUTANON M, KAOJARERN S, RATTANANENYA T. Effect of lung irradiation on mice following paraquat intoxication. Chest 1992; 101: 833-835.
25. NAKAGOME K, DOHI M, OKUNISHI K, TANAKA R, MIYAZAKI J, YAMAMOTO K. In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-in the lung. Thorax 2006; 61: 886-894.
26. RAMAIAH SK, JAESEHKE H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 2007; 35: 757-766.
27. BECK-SCHIMMER B, MADJDPOUR C, KNELLER S, ZIEGLER U, PASCH T, WÜTHRICH RP, WARD PA, SCHIMMER RC. Role of alveolar epithelial ICAM-1 in lipopolysaccharide-induced lung inflammation. Eur Respir J 2002; 19: 1142-1150.
28. HAMAGUCHI Y, NISHIZAWA Y, YASUI M, HASEGAWA M, KABURAGI Y, KOMURA K, NAGAOKA T, SAITO E, SHIMADA Y, TAKEHARA K, KADONO T, STEEBER DA, TEDDER TF, SATO S. Intercellular adhesion molecule-1 and Lselectin regulate bleomycin-induced lung fibrosis. Am J Pathol 2002; 161: 1607-1618.
29. LAUDES IJ, GUO RF, RIEDEMANN NC, SPEYER C, CRAIG R, SARMA JV, WARD PA. Disturbed homeostasis of lung intercellular adhesionmolecule-1 and vascular cell adhesion molecule-1 during sepsis. Am J Pathol 2004; 164: 1435-1445.
30. BARTON WW, WILCOXEN S, CHRISTENSEN PJ, PAINE R. Disparate cytokin regulation of ICAM-1 in rat alveolar epithelial cells and pulmonary endothelial cells in vitro. Am J Physiol 1995; 269: 127-135.
31. BENYON RC, ARTHUR MJ. Extracellular matrix degradation and the role of hepatic stellate cells. Semin. Liver Dis 2001; 21: 373-384.
32. SIEVERS HH, FREUND-KAAS C, ELEFTHERIADIS S, FISCHER T, KUPPE H, KRAATZ EG, BECHTEL JF. Lung protection during total cardiopulmonary bypass by isolated lung perfusion: preliminary results of a novel perfusion strategy. Ann Thorac Surg 2001; 74: 1167-1172.
33. STEINBERG J, FINK G, PICONE A, SEARLES B, SCHILLER H, LEE HM, NIEMAN G. Evidence of increased matrix metalloproteinase-9 concentration in patients following cardiopulmonary bypass. J Extra Corpor Technol 2001; 33: 218-222.
34. SANTANA AN, KAIRALLA RA, CARVALHO CR. Potential role of statin use in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008; 177: 1048.
35. RUIZ V, ORDÓÑEZ RM, BERUMEN J, RAMÍREZ R, UHAL B, BECERRIL C, PARDO A, SELMAN M. Unbalanced collagenases/ TMP-1 expression and epithelial apoptosis in experimental lung fibrosis. Am J Physiol Lung Cell Mol Physio1 2003; 285: 1026-1036.
36. SHEPARD D. Pulmonary fibrosis: a cellular overreaction or a failure of communication. Clin Invest 2001; 107: 1501-1502.
37. SUGA M, IYONAGA K, OKAMOTO T, GUSHIMA Y, MIYAKAWA H, AKAIKE T, ANDO M. Elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2000; 162: 1949-1956.
38. X L LI, L SUN, J F SHEN, H M CAO. Investigation on tolerance of magnesium isoglycyrrhizinate injection in healthy volunteers. China Pharmacy 2006; 17: 279-282.
39. TANDON A, TANDON BN, BHUJAWALA RA. Clinical spectrum of acute sporadic hepatitis E and possible benefit of glycyrrhizin therapy. Hepatol Res 2003; 23: 55-61.
40. GENOVESE T, MENEGAZZI M, MAZZON E, CRISAFULLI C, DI PAOLA R, DAL BOSCO M, ZOU Z, SUZUKI H, CUZZOCREA S. Glycyrrhizin reduces secondary inflammstory process after spinal cord compression injury in mice. Shock 2008; 31: 367-375.
41. YU Z, OHTAKI Y, KAI K, SASANO T, SHIMAUCHI H, YOKOCHI T, TAKADA H, SUGAWARA S, KUMAGAI K, ENDO Y. Critical roles of platelets in lipopolysaccharideinduced lethality: effects of glycyrrhizin and possible strategy for acute respiratory distress syndrome. Int Immunopharmacol 2005; 5: 571-580.
42. ZHENG QZ, LOU YJ. Pathologic characteristics of immunologic injury in primary cultured rat hepatocytes and protective effect of glycyrrhizin in vitro. Acta Pharmacol Sin 2003; 24: 771-777.